Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$7.07 0.10 (1.43%)
2/9/2010 4:01 PM

Elan Corp, plc (ADR) (ELN)

CAPS Rating:
****

The Company's Biopharmaceuticals unit is engaged in research, development and commercial activities and its EDT unit focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ELN

Add Stock to Watchlist

What the Community Thinks

Elan Corp, plc (ADR) At A Glance

Current Price: $7.07
Last Trade Time: 2/9/2010 4:01 PM
Open: $0.00
Previous Close: $6.97
Daily Range: $6.95 - $7.15
52-Week Range: $4.61 - $8.59
Volume: 2,724,661
Market Cap: $3.33B
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

ELN VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

3

Elan Corp, plc (ADR) (ELN)

Avatar latimerburned (81.51) Submitted: 8/15/09 9:11 AM

They have taken away a lot of the financial risk with the JNJ deal so now its all about Tysabri and Alzheimers. I think that the benefits of Ty outweigh the risks as they are learning how to manage the drug so this one should do very well.

Replies: 1 | Reply | Permalink

Top Bear Pitch

Recs

2

Elan Corp, plc (ADR) (ELN)

Avatar michjksn (< 20) Submitted: 2/27/09 1:42 PM

Historically poorly run company. One product which causes death all too often/terrible press. No products on horizon, including Bap, worth anything other than being money pits for underachievement. What R&D there was, has been all but killed off due to debt load, which is overwhelming and coming ...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 207 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (ELN)

Avatar Biotech2010 (40.47) Submitted: 1/26/10 8:50 PM : Outperform Start Price: $7.73 ELN Score: -6.75

@6.77

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ELN)

Avatar Contralogic (58.48) Submitted: 1/23/10 10:19 AM : Outperform Start Price: $8.05 ELN Score: -9.46

Elan -- will be a player in the biotech across the next 5 years.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ELN)

Avatar Rzani (< 20) Submitted: 1/13/10 1:45 PM : Outperform Start Price: $7.83 ELN Score: -3.46

I think either the assay, the phase 2 results or a buyout will bring good news for elan in the near future.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ELN)

Avatar anling001 (24.90) Submitted: 1/09/10 12:34 PM : Outperform Start Price: $7.52 ELN Score: 0.74

Promising Alzheimer drug candidates.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ELN)

Avatar jeffrycooks (86.98) Submitted: 12/30/09 1:14 AM : Outperform Start Price: $6.46 ELN Score: 13.91

a spec play to watch for fun- think after the winter doldrums are past this one will be up 25-30% or more in 1 year

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 207 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 6 of 6  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRBCCapMkts 86.33 01/22/09 Underperform NS $7.07 0%+32.38%+32.38
TrackCanaccord 86.15 01/14/09 Outperform NS $8.92-20.74%+25.81%-46.55
TrackBreanMurray 86.47 07/11/08 Underperform NS $34.91-79.75%-10.43%+69.32
TrackMerriman < 20 06/11/08 Outperform NS $26.33-73.15%-18.51%-54.63
TrackEdwardOwens 98.91 09/30/07 Outperform NS $21.04-66.40%-26.38%-40.02 Toggle the visibility of 60-Second Pitch and replies
TrackJimCramer < 20 08/28/07 Underperform 3W $18.86-62.51%-21.47%+41.05

Results 1 - 6 of 6  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD01 906ms